Monitoring and maintaining a higher tacrolimus trough level in the first month after transplantation is essential to avoid acute rejection, according to investigators. Maintaining a tacrolimus trough ...

Kidney transplant recipients typically take the immunosuppressant drug tacrolimus to prevent rejection, and some patients experience large fluctuations in blood levels of tacrolimus even when the dose ...

Please provide your email address to receive an email when new articles are posted on . In a retrospective pediatric cohort study, researchers observed 426 patients who underwent kidney-only ...

Tacrolimus is a mainstay immunosuppressant used to prevent rejection in kidney transplant recipients. However, its narrow therapeutic index necessitates routine monitoring, as intrapatient variability ...

H OUSTON -- Rate of successful kidney transplantation was similar in adults, ages 65 and older, who received a lower dose ...

At the same time, in collaboration with Profs Michel Mourad and Vincent Haufroid of the UCLouvain Saint-Luc University Hospital, Prof. Elens carried out clinical tests on faecal matter taken from some ...

A 38-year-old Japanese woman with a 9-year history of severe aplastic anemia that did not respond to corticosteroids, antithymocyte globulin, cyclosporine or growth factor therapy was referred to our ...

A new study out of Japan explored the long-term safety and efficacy of tacrolimus, an immunosuppressive drug that blocks T-cell activation and suppresses autoantibody production, in people with lupus ...

Kidney transplant survival is shorter, on average, in Black recipients compared to white recipients receiving similar treatment. Although Black people make up only 13% of the population, they ...

In a study, the calcineurin inhibitor tacrolimus proved to be noninferior to intravenous cyclophosphamide. Tacrolimus, a calcineurin inhibitor, appears to be an effective alternative to ...